Sign in
4

Changes in Ownership

Neumora Therapeutics, Inc. Filed Acc 0001062993-23-018469

10% owner bought 100,740 shares at an average $11.19 ($1,127,064)

From the SEC's structured data for this filing

Trades in this filing

ARCH Venture Partners XII, LLC · 10% owner

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-22 Purchase : show line 1 in the form +40,000 $11.14 $445,600 3,664,143 I
2023-09-25 Purchase : show line 2 in the form +30,773 $10.80 $332,348 3,694,916 I
2023-09-25 Purchase : show line 3 in the form +29,967 $11.65 $349,116 3,724,883 I
Open-market purchases · 100,740 sh · avg $11.19 · $1,127,064
Loading xslF345X05/form4.xml…